Results 201 to 210 of about 7,080,207 (344)

Upregulation of senescence-associated gene expression levels in human gingival tissue affected by periodontitis. [PDF]

J Periodontol
Kim SJ, Batra C, Yoshii H, Hamada Y, Ueki Y, Eckert GJ, John V, Kittaka M.   +7 more
europepmc   +1 more source

Evaluation of IL-4, MIP-1α, and MMP-9 gene expression levels in peri-implant tissues in peri-implantitis. [PDF]

Braz Dent J, 2023
Giro G, Taira J, Andriani F, Watinaga S, Bastos MF, Shibli JA.   +5 more
europepmc   +1 more source

Dammarenediol II enhances etoposide‐induced apoptosis by targeting O‐GlcNAc transferase and Akt/GSK3β/mTOR signaling in liver cancer

Molecular Oncology, EarlyView.
Etoposide induces DNA damage, activating p53‐dependent apoptosis via caspase‐3/7, which cleaves PARP1. Dammarenediol II enhances this apoptotic pathway by suppressing O‐GlcNAc transferase activity, further decreasing O‐GlcNAcylation. The reduction in O‐GlcNAc levels boosts p53‐driven apoptosis and influences the Akt/GSK3β/mTOR signaling pathway ...
Jaehoon Lee, Byung‐Cheol Han, Gi‐Bang Koo, Jihye Park, Mijin Kwon, Young Bin Park, Jae‐Mun Choi, Seung‐Ho Lee, Sangho Roh   +8 more
wiley   +1 more source

In Silico Characterisation and Determination of Gene Expression Levels of the CPK Family Under Saline Stress Conditions in Chenopodium quinoa Willd. [PDF]

Int J Mol Sci
Lima-Huanca L, Alvarez-Vasquez A, Valderrama-Valencia M, Condori-Pacsi S.   +3 more
europepmc   +1 more source

Analysis of ADORA2A, MTA1, PTGDS, PTGS2, NSF, and HNMT Gene Expression Levels in Peripheral Blood of Patients with Early Stages of Parkinson's Disease. [PDF]

Biomed Res Int, 2023
Semenova EI, Partevian SA, Shulskaya MV, Rudenok MM, Lukashevich MV, Baranova NM, Doronina OB, Doronina KS, Rosinskaya AV, Fedotova EY, Illarioshkin SN, Slominsky PA, Shadrina MI, Alieva AK.   +13 more
europepmc   +1 more source

Chromatin-level Analysis of Regulation of Gene Expression

RADIOISOTOPES, 1988
M, Harata, S, Mizuno
openaire   +3 more sources

TRAIL‐PEG‐Apt‐PLGA nanosystem as an aptamer‐targeted drug delivery system potential for triple‐negative breast cancer therapy using in vivo mouse model

Molecular Oncology, EarlyView.
Aptamers are used both therapeutically and as targeting agents in cancer treatment. We developed an aptamer‐targeted PLGA–TRAIL nanosystem that exhibited superior therapeutic efficacy in NOD/SCID breast cancer models. This nanosystem represents a novel biotechnological drug candidate for suppressing resistance development in breast cancer.
Gulen Melike Demirbolat, Aslihan Kucuk, Omer Erdogan, Samed Ozer, Bensu Kozan, Tugba Cuceli, Erkan Gumus, Evrim Cevik, Ozge Cevik   +8 more
wiley   +1 more source

Assessment of TSPO Gene Expression Levels in Colorectal Cancer Tumors: A Paired Sample Study. [PDF]

Cancer Rep (Hoboken)
Karami Gorji H, Karimi M, Mortezazadeh M, Shirsalimi N, Akhshabi S, Yousefi Ladmakhi A, Kashani M, Seyyed Mahmoudi ST, Mofidi A, Rezaei A.   +9 more
europepmc   +1 more source

Diverse environmental perturbations reveal the evolution and context-dependency of genetic effects on gene expression levels. [PDF]

Genome Res, 2022
Lea AJ, Peng J, Ayroles JF.
europepmc   +1 more source

Targeting p38α in cancer: challenges, opportunities, and emerging strategies

Molecular Oncology, EarlyView.
p38α normally regulates cellular stress responses and homeostasis and suppresses malignant transformation. In cancer, however, p38α is co‐opted to drive context‐dependent proliferation and dissemination. p38α also supports key functions in cells of the tumor microenvironment, including fibroblasts, myeloid cells, and T lymphocytes.
Angel R. Nebreda
wiley   +1 more source